DAILY MORNING NOTE | 1 September 2025

Trades Initiated in Past Week

Factsheets


Week 36 equity strategy: The largest gainers in August were property, construction, and oil and gas-related stocks. Under our coverage, stocks that rallied the most were PropNex (+74%), Soilbuild Construction (+68%) and Pacific Radiance (+61%). Other sectors with strong performance were commodities and healthcare, such as CNMC (+26%), Q&M Dental (+25%), China Aviation (+21%) and Thomson Medical (+17%). We find small-mid cap stocks moving towards the high teens to low twenties valuations. With the dearth in growth and huge liquidity on the horizon, investors must pay up. Even cyclical companies such as real estate agencies and construction companies that traded sub-10x PE in the past are heading towards their mid-teens, especially with the upswing in earnings. We expect valuation expansion to remain a significant theme. Stocks with growth and still trading at 10x forward PE and below include Soilbuild Construction (7x), Pacific Radiance (7x), China Aviation Oil (10x), and Thakral (10x).

The outlook for the offshore support vessels (OSV) remains positive. Demand from the Middle East continues to grow as countries raise their production targets to maintain market share, and cost per barrel low. Another new source of demand is the installation of offshore wind farms. Taiwan will ramp in 2027, followed by South Korea and Japan. Existing global OSV vessels are old, with orders covering only 6% of the existing fleet. Singapore companies with OSV building and chartering capabilities include Pacific Radiance, Marco Polo, and Penguin International.

We came out of Singtel investor day last week more positive on the outlook. The medium-term special dividend (aka value realisation dividend) is likely to continue for five years, and at the higher end, 6 cents (S$1bn). The pool of assets to be monetised is larger than the S$9bn (which $4bn realised) because the Bharti stake alone available for sale is $12.5-13bn, and there is an opportunity to dispose of more real estate and reduce stakes in subsidiaries. The two largest drivers of the share price will be Bharti’s growth. It is the gift that keeps on giving. Earnings jumped 95% YoY to S$391mn in the June quarter, and the outlook is still strong with mobile prices continually rising, especially with a pending IPO by its competitor. Dividends will also jump as capital intensity eases. Singapore doubling its data centre capacity in 2026 and rolling out GPU-as-a-service for sovereign AI is the next growth driver. On Singapore mobile prices, it was more fingers crossed and Star Wars Episode IV – A New Hope.

Paul Chew
Head Of Research
paulchewkl@phillip.com.sg


Singapore stocks finished the week on a cheerful note amid rising expectations of a September rate cut by the Federal Reserve. Stocks rose 0.4 per cent or 15.92 points to 4,269.70 on Friday (Aug 29). Across the broader market, gainers beat losers 314 to 202, after 1.2 billion securities worth S$1.4 billion changed hands. Keppel led the gains, rising 3.2 per cent or S$0.27 to S$8.75. Thai Beverage was the biggest decliner on the index, losing 1.1 per cent or S$0.005 to finish at S$0.46.

Wall Street stocks fell on Friday (Aug 29) heading into a long weekend, with key employment data due next week alongside other indicators of the economy’s health.
The Dow Jones Industrial Average slipped 0.2 per cent to 45,544.88, while the broad-based S&P 500 Index dropped 0.6 per cent to 6,460.26.
The tech-focused Nasdaq Composite Index tumbled 1.2 per cent to 21,455.55.


Singapore Technical Highlights

Factsheets* ^ denotes companies placed on SGX Watch-list


TOP 5 GAINERS & LOSERS

Factsheets


Events Of The Week

Factsheets


SG

Local eatery Superfood Kitchen will enter voluntary liquidation with operations at its last outlet, in Raffles City, ceasing on Sunday (Aug 31). Superfood Kitchen faces mounting losses and was not able to agree on rental rates with the landlord, said its Singapore-listed parent, Autagco, in a Sunday bourse filing.

Healthcare provider Thomson Medical has swung into the red with a net loss of S$34.7 million for its six months ended Jun 30, compared with a net profit of S$12.1 million in the previous corresponding period. This came despite a 6.9 per cent uptick in revenue to S$195.6 million for the second half of the 2025 financial year, from S$183 million in H2 FY2024, its financial statement released on Friday (Aug 29) showed

iFast chief Lim Chung Chun ups shareholding, acquiring 60,000 shares at an average price of S$8.29 a share.

Cathay Cineplexes owner mm2 Asia widened its net loss in the second half of its fiscal year ended Mar 31 by more than 10 times to S$101.3 million, from S$8.7 million in the previous corresponding period. This comes despite a 21 per cent increase in revenue for the six months to S$79.7 million, from S$65.9 million in the year-ago period.

Integrated heavy engineering, construction and maintenance service provider Civmec posted a 50.7 per cent drop in net profit to A$16 million (S$13.4 million) for its six months ended Jun 30, from A$32.5 million in the previous corresponding period. This came alongside a 43.1 per cent fall in revenue to A$307.7 million for the second half of its financial year, from A$541.1 million in H2 FY2024.

Food and agri-business giant Olam said that it will close Jiva Ag, a digital farmer services platform developed by the group’s venture arm, Nupo Ventures. A total of 606 employees will be affected.


US

Meta is considering partnerships with rivals Google or OpenAI to enhance artificial intelligence (AI) features in its applications. Leaders at Meta’s new AI organisation, Meta Superintelligence Labs, have explored integrating Google’s Gemini model to deliver conversational, text-based responses for queries submitted to Meta AI, the company’s primary chatbot.

Meta is adding new teenager safeguards to its artificial intelligence (AI) products by training systems to avoid flirty conversations and discussions of self-harm or suicide with minors, and by temporarily limiting their access to certain AI characters.

Oil prices fell on Friday (Aug 29) as traders looked toward weaker demand in the US, the world’s largest oil market, and a boost in supply this autumn from Opec and its allies. Brent crude futures for October delivery, which will expire on Friday, were down 49 cents, or 0.7 per cent, at US$68.13 a barrel, while the more active contract for November was down 57 cents, or 0.8 per cent, at US$67.41. West Texas Intermediate crude futures were 60 cents, or 0.93 per cent, lower at US$63.99.


Source: SGX Masnet, Bloomberg, Channel NewsAsia, Reuters, CNBC, WSJ, The Business Times, The Edge Singapore, PSR


RESEARCH REPORTS

Singapore Telecommunications Ltd – Mobile price repair is largely underway

Recommendation: ACCUMULATE; TP S$4.86; Last close: S$4.3100; Analyst Paul Chew

  • 2025 Investor Day: Singtel mentioned that the asset monetisation target is much larger than S$9bn, the scaling up of its data centre as Singapore capacity doubles, finalised its GPU-as-a-service business model, and the need to adopt AI at scale to secure the competitive edge in cost and service levels.
  • Countries experiencing mobile price repair are India, Thailand, and Australia. Mobile prices in the Philippines are bottoming, but Indonesia’s price repair is still fragile. Singapore remains in a downward trend, with fingers crossed expectations following the planned consolidation of Simba and M1.
  • We maintain our ACCUMULATE recommendation with a higher target price of S$4.86 (prev. S$4.40). We increased our EV/EBITDA multiple from 7x to 8x, aligning with industry peers as operations improve in Australia and earnings from data centres surge. Our discount on associate valuations has narrowed from 15% to 10%. Visibility to monetise key associates has increased. Except for Singapore and Indonesia, most countries have a clear line of sight for mobile price repair. Value realisation (or medium-term special) dividends are likely to be at the higher range of 6 cents with the larger pipeline of assets to monetise.


PSR Stocks Coverage

Factsheets


For more information, please visit:

https://www.stocksbnb.com/singapore-stocks-coverage/


Upcoming Webinars

Corporate Insights by Lum Chang Creations

Date & Time: 5 September 25 | 12PM-1PM

Register: poems-20250905-127587


Corporate Insights by Yoma Strategic

Date & Time: 9 September 25 | 12PM-1PM

Register: poems-20250909-128571


Corporate Insights by ComfortDelGro

Date & Time: 10 September 25 | 12PM-1PM

Register: poems-20250910-127804


Corporate Insights by LMS Compliance

Date & Time: 17 September 25 | 12PM-1PM

Register: poems-20250917-127971


Corporate Insights by Keppel REIT

Date & Time: 23 September 25 | 12PM-1PM

Register: poems-20250923-127589


POEMS Podcast:

Research Videos

Weekly Market Outlook: Frencken Group, Wee Hur Holdings, StarHub, Hyphens Pharma & More!
Date: 25 Aug 2025

Click here for more on Market Outlook.
Sign up for our webinars here, and be among the first to receive economy and market updates.

PHILLIP RESEARCH IN 3 MINS

Follow our Socials

Facebook Social Icon Instagram Icon Twitter Social Icon Youtube Social Icon Linkedin Social Icon TikTok Social Icon Spotify Social Icon

Join our Singapore Equity Research Community on POEMS Mobile 3 App for the latest research reports, market updates, insights and more

Click to join!

Disclaimer

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.

Confidentiality Note

This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com